McKesson Co. (NYSE:MCK) Shares Sold by HMS Capital Management LLC

HMS Capital Management LLC lowered its stake in McKesson Co. (NYSE:MCK) by 5.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,585 shares of the company’s stock after selling 272 shares during the quarter. McKesson comprises about 1.1% of HMS Capital Management LLC’s portfolio, making the stock its 23rd biggest holding. HMS Capital Management LLC’s holdings in McKesson were worth $2,267,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently bought and sold shares of MCK. LRI Investments LLC purchased a new position in McKesson in the first quarter valued at $28,000. Wolff Wiese Magana LLC grew its position in shares of McKesson by 742.9% during the third quarter. Wolff Wiese Magana LLC now owns 59 shares of the company’s stock worth $29,000 after buying an additional 52 shares in the last quarter. ORG Wealth Partners LLC purchased a new stake in shares of McKesson during the third quarter worth approximately $40,000. Carmichael Hill & Associates Inc. acquired a new stake in McKesson in the second quarter valued at approximately $52,000. Finally, Centennial Bank AR acquired a new position in McKesson during the 2nd quarter worth approximately $53,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling

In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the company’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $561.10, for a total value of $2,105,808.30. Following the transaction, the chief executive officer now directly owns 78,586 shares in the company, valued at approximately $44,094,604.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.11% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. Evercore ISI decreased their price target on McKesson from $660.00 to $630.00 and set an “outperform” rating for the company in a report on Thursday, August 8th. Leerink Partners lowered their price target on McKesson from $665.00 to $630.00 and set an “outperform” rating for the company in a report on Monday, October 7th. Barclays raised their price objective on shares of McKesson from $596.00 to $616.00 and gave the stock an “overweight” rating in a report on Thursday, August 8th. Baird R W downgraded shares of McKesson from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 24th. Finally, StockNews.com cut shares of McKesson from a “buy” rating to a “hold” rating in a research report on Friday, September 27th. Five equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $610.86.

McKesson Trading Down 0.1 %

Shares of MCK opened at $525.27 on Wednesday. McKesson Co. has a 12-month low of $431.35 and a 12-month high of $637.51. The stock has a market cap of $68.12 billion, a P/E ratio of 23.49, a PEG ratio of 1.23 and a beta of 0.44. The company has a 50-day moving average of $511.11 and a two-hundred day moving average of $550.62.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.21 by $0.67. The firm had revenue of $79.28 billion for the quarter, compared to analyst estimates of $82.53 billion. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. McKesson’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $7.27 EPS. As a group, analysts forecast that McKesson Co. will post 31.92 EPS for the current fiscal year.

McKesson Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Monday, December 2nd will be paid a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.54%. The ex-dividend date of this dividend is Monday, December 2nd. McKesson’s payout ratio is currently 12.70%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.